Centene Forecasts 40% EPS Growth in 2026, Eyes Margin Recovery and Medicaid Stability.

Centene Corporation expects over 40% EPS growth in 2026 while targeting margin recovery and Medicaid stability. The company reported a Q4 adjusted diluted loss per share of ($1.19) and a full-year 2025 adjusted diluted EPS of $2.08. Despite the challenges in 2025, Centene's disciplined execution enabled it to close the year with a stable Medicaid business and a focus on future growth.